Osta Tablet

About Osta 10 mg Tablet

Osta 10 mg tablet is a medicine made by The ACME Laboratories Ltd. It is a bisphosphonate preparation.

There are 4 brands of Alendronic Acid listed in Bangladesh. The lowest listed price is Bonemas 10 mg Tablet at ৳ 30.00 per unit.

What is Osta 10 mg Tablet?

Osta comes as a tablet with 10 mg of Alendronic Acid, from The ACME Laboratories Ltd. Bisphosphonates work by binding to bone and reducing the activity of osteoclasts, the cells that break down bone. Its active ingredient is Alendronic Acid. Ask your doctor or pharmacist if you are unsure about it.

Uses of Osta

It is a bisphosphonate preparation. Do not start, stop or change the medicine on your own; ask your doctor if you have questions about what it is being used for. Alendronic Acid works on the bone-removing cells and slows bone loss, and treatment has been shown to increase bone mass and reduce fractures of the hip and spine. Ask your doctor whether it is right for your condition.

How to use Osta

Take Osta exactly as your doctor tells you. Osta is taken by mouth. Swallow the tablet with water. The dose and course are decided by your doctor, so follow their instructions exactly and do not change them on your own. Do not change the dose or stop early without asking your doctor.

Side effects of Osta

Less often, rash, redness of the skin, nausea, vomiting, peptic ulceration and a temporary fall in serum calcium and phosphate may occur. Reaction such as hives and swelling have been reported. Some people notice constipation, diarrhoea, wind, nausea or vomiting. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.

Safety and precautions

It is not suitable for people with certain oesophageal problems, low blood calcium, or those unable to sit or stand upright as instructed, and it should not be given to anyone allergic to any ingredient. Before using Osta, tell your doctor about any problems with the esophagus, such as stricture or achalasia, or if you cannot stand or sit upright for a period of time. Osta should not be used in pregnancy or while breastfeeding.

Frequently asked questions

What is Osta used for?

It is a bisphosphonate preparation. Do not start, stop or change the medicine on your own; ask your doctor if you have questions about what it is being used for.

How should I take Osta?

Take Osta exactly as your doctor tells you. Osta is taken by mouth.

Can Osta cause side effects?

Less often, rash, redness of the skin, nausea, vomiting, peptic ulceration and a temporary fall in serum calcium and phosphate may occur. Reaction such as hives and swelling have been reported.

Can I use Osta in pregnancy or while breastfeeding?

It is not suitable for people with certain oesophageal problems, low blood calcium, or those unable to sit or stand upright as instructed, and it should not be given to anyone allergic to any ingredient. Before using Osta, tell your doctor about any problems with the esophagus, such as stricture or achalasia, or if you cannot stand or sit upright for a period of time.

Indications

Alendronic acid is indicated for the-
  • Treatment of Osteoporosis in Postmenopausal Women: Alendronic acid is indicated for the treatment of osteoporosis in postmenopausal women. In postmenopausal women, Alendronic acid increases bone mass and reduces the incidence of fractures, including those of the hip and spine.
  • ... Read more
Alendronic acid is indicated for the-
  • Treatment of Osteoporosis in Postmenopausal Women: Alendronic acid is indicated for the treatment of osteoporosis in postmenopausal women. In postmenopausal women, Alendronic acid increases bone mass and reduces the incidence of fractures, including those of the hip and spine.
  • Prevention of Osteoporosis in Postmenopausal Women: Alendronic acid is indicated for the prevention of postmenopausal osteoporosis.
  • Treatment to Increase Bone Mass in Men with Osteoporosis: Alendronic acid is indicated for treatment to increase bone mass in men with osteoporosis.
  • Treatment of Glucocorticoid-Induced Osteoporosis: Alendronic acid is indicated for the treatment of glucocorticoid-induced osteoporosis in men and women receiving glucocorticoids in a daily dosage equivalent to 7.5 mg or greater of prednisone and who have low bone mineral density.
  • Treatment of Paget's Disease of Bone: Alendronic acid is indicated for the treatment of Paget’s disease of bone in men and women. Treatment is indicated in patients with Paget's disease of bone who have alkaline phosphatase at least two times the upper limit of normal, or those who are symptomatic, or those at risk for future complications from their disease.

Pharmacology

Alendronate is a bisphosphonate that binds to bone hydroxyapatite and specifically inhibits the activity of osteoclasts, the bone-resorbing cells. Alendronate reduces bone resorption with no direct effect on bone formation, although the latter process is ultimately reduced because bone resorption and formation are coupled during bone turnover.

Animal studies have indicated the following mode of action. At the cellular level, alendronate shows preferential localization to sites of bone resorption, specifically under osteoclasts. The osteoclasts adhere normally to the bone surface but lack the ruffled border that is indicative of active resorption. Alendronate does not interfere with osteoclast recruitment or attachment, but it does inhibit osteoclast activity. Studies in mice on the localization of radioactive [3H] alendronate in bone showed about 10-fold higher uptake on osteoclast surfaces than on osteoblast surfaces. Bones examined 6 and 49 days after [3H] alendronate administration in rats and mice, respectively, showed that normal bone was formed on top of the alendronate, which was incorporated inside the matrix. While incorporated in bone matrix, alendronate is not pharmacologically active. Thus, alendronate must be continuously administered to suppress osteoclasts on newly formed resorption surfaces. Histomorphometry in baboons and rats showed that alendronate treatment reduces bone turnover (i.e., the number of sites at which bone is remodeled). In addition, bone formation exceeds bone resorption at these remodeling sites, leading to progressive gains in bone mass.

Dosage & Administration

Treatment of Osteoporosis in Postmenopausal Women: The recommended dosage is one 70 mg tablet once weekly or one bottle of 70 mg oral solution once weekly or one 10 mg tablet once daily.

Prevention of Osteoporosis in Postmenopausal Women: The recommended dosage is one 35 mg tablet once weekly or one 5 mg tablet once daily.

Treatment to Increase Bone Mass in Men with Osteoporosis: The recommended dosage is one 70 mg tablet once weekly or one bottle of 70 mg oral solution once weekly or one 10 mg tablet once daily.

Treatment of Glucocorticoid-Induced Osteoporosis: The recommended dosage is one 5 mg tablet once daily, except for postmenopausal women not receiving estrogen, for whom the recommended dosage is one 10 mg tablet once daily.

Treatment of Paget's Disease of Bone: The recommended treatment regimen is 40 mg once a day for six months.

Interaction

The incidence of upper gastrointestinal side effects are increased with the concomitant use of non-steroidal anti-inflammatory agents and aspirin. Absorption of Alendronate is reduced in the presence of antacids and calcium supplements.

Contraindications

Alendronic acid is contraindicated in patients with the following conditions: 
  • Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia.
  • Inability to stand or sit upright for at least 30 minutes.
  • Do not administer Alendronic acid oral solution to patients at increased risk of aspiration.
  • Hypocalcemia.
  • Hypersensitivity to any component of this product. Hypersensitivity reactions including urticaria and angioedema have been reported.

Side Effects

The commonest symptomatic side effects are constipation, diarrhoea, oesophageal ulcer, flatulence, dysphagia, musculoskeletal pain, headache, rarely rash, erythema, transient decrease in serum calcium and phosphate, nausea, vomiting, peptic ulceration, hypersensitivity reactions including urticaria and angio-oedema.

Pregnancy & Lactation

Alendronic acid should not be given to pregnant women or nursing mother.

Precautions & Warnings

  • Upper Gastrointestinal Adverse Reactions can occur. Instruct patients to follow dosing instructions. Discontinue if new or worsening symptoms occur.
  • Hypocalcemia can worsen and must be corrected prior to use.
  • Severe Bone, Joint, Muscle Pain may occur. Discontinue use if severe symptoms develop.
  • Osteonecrosis of the Jaw has been reported.
  • Atypical Femur Fractures have been reported. Patients with new thigh or groin pain should be evaluated to rule out an incomplete femoral fracture.

Storage Conditions

Store in a well-closed container at room temperature, 15-30°C

Alternative brands of Alendronic Acid

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.